Trial of a Non Electric Infant Warmer for Prevention and Treatment of Hypothermia in Rwanda
Stepped Wedge Randomized Control Trial of a Non Electric Infant Warmer for Prevention and Treatment of Hypothermia in Rwanda
1 other identifier
interventional
3,179
1 country
1
Brief Summary
Hypothermia contributes to a significant portion of neonatal deaths. Kangaroo Mother Care (KMC) is a safe and effective method of warming; however, it is not always feasible, for example in settings such as resuscitation or clinical instability. Electric warmers are the standard of care in developed countries, but are extremely costly, complicated with risk of causing both hypo and hyperthermia with misuse, and often not reliable in settings without stable electricity. After two encouraging pilot studies totaling 204 uses in 2 district hospitals and 4 health centers in rural Rwanda, the investigators aim to further study the warmer in a stepped wedge prospective controlled trial in hospital setting to assess safety and efficacy of the Infant Warmer based on clinical observation and feasibility based on observer audits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2019
CompletedFirst Posted
Study publicly available on registry
March 26, 2019
CompletedStudy Start
First participant enrolled
November 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedFebruary 11, 2021
February 1, 2021
8 months
March 21, 2019
February 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Ability to regulate infant body temperature
The infant warmer will be evaluated on its ability to achieve and maintain a normal body temperature for patients who are hypothermic and those patients at risk of hypothermia because of a \< 2.5 kg birth weight or \< 35 week gestational age. Infants temperature will be measured, using a thermometer to ensure the body temperature will increase but not exceed 37.5°C.
up to 6 months
Incidence of adverse events as assessed by staff observation
The investigators will assess the safety of the infant warmer by observing any adverse reactions such as skin irritations or higher than usual patient temperature (\>37.5°C). The safety of the warmer will be measured by study staff observation, measuring the temperature of the warmer with a thermistor instrument, measuring the infant's temperature with a thermometer, as well an investigator-developed Observer Audit Form. The Observer Audit Form is a battery of nine questions which includes eight yes/no questions and one free response. The questions evaluate such topics as whether the warmer was cleaned, the infant was positioned correctly, if adverse events were present, etc.
up to 6 months
Secondary Outcomes (2)
Studying the practicality of applying the device in a clinical setting
up to 6 months
Functionality
up to 6 months
Study Arms (2)
Non-Electric Infant Warmer
EXPERIMENTALIn line with current recommended practice, the mother will be encouraged to provide KMC whenever possible. For hypothermic infants, if the temperature is not rising by ½°C per hour with KMC alone, the Infant Warmer will be offered as an addition. In these cases, the heat will be provided by placing the Infant Warmer over the infant's back while the mother provides KMC. If the mother is not available for KMC at any time, the infant will be warmed exclusively with the Infant Warmer by being placed directly on the warmer as it lies flat. Use of hat and socks will be encouraged by additional clothes will only be added in addition to the warmer per caregiver request, as it reduces heat transfer.
Control
NO INTERVENTIONData such as infant temperature, date of birth, etc. will be collected from those who enroll in the control group. No experimental intervention will be administered.
Interventions
Electric warmers are the standard of care in developed countries, but are extremely costly, complicated with risk of causing both hypo and hyperthermia with misuse, and often not feasible in settings without stable electricity. Through a multi-institutional collaboration, the investigators have developed an electricity-free infant warmer.
Eligibility Criteria
You may qualify if:
- Any infant with the following criteria for whom caregiver not available for KMC, or KMC is not adequate (less than 0.5°C/hour rise in temperature):
- Axillary temperature \< 36.5 °C
- a) If an electric warmer is available and the infant's temperature is \< 35°C, then the infant will start by being warmed on the electric warmer until the infant's temperature reaches 36°C, then can start non-electric Infant Warmer use.
- Infants at-risk for hypothermia (criteria: estimated post-menstrual age of \< 35 weeks or current body weight of \< 2.5 kg).
You may not qualify if:
- Any infant whose family is unwilling to consent to the study.
- Mothers who are critically ill at the time of infant eligibility or deemed not medically stable by nursing staff to be approached for consent.
- Any infant with a contraindication to KMC (medical instability) and electrical heating source available.
- Any infant with initial temperature \< 35°C and electrical heating source available.
- Infants requiring phototherapy.
- Infants with significant skin condition.
- Stop Criteria:
- If an electric heating source is available, the infant will be taken off of the study and warmed with an appropriate source of electric heat if the infant:
- If an electric heating source is available, the infant will be taken off of the study and warmed with an appropriate source of electric heat if the infant:
- i. Has temp \< 36 °C while receiving maximum non-electric heat exposure and temperature decreases on any measurement ii. Has temp \< 36 °C while receiving maximum non-electric heat exposure and temperature does not begin to rise within 30 minutes iii.Has temp \< 36 °C while receiving maximum non-electric heat exposure and not heating at a rate of \> ½ °C per hour until temperature \>36.5°C iv.Has a temperature that falls below 36°C despite maximum non-electric heat exposure
- Definition of maximum non-electric heat exposure:
- IW, KMC, hat; if KMC available
- IW, blanket, hat; if KMC not available
- Blanket, hat; while seeking caregiver for KMC and/or preparing IW if KMC and IW not available
- Has temperature \> 37.5 °C
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Children's Hospitallead
- Ministry of Health, Rwandacollaborator
- Rwandan Biomedical Counsel (RBC)collaborator
- Harvard Medical School (HMS and HSDM)collaborator
- Partners in Healthcollaborator
- Rwanda National Ethics Committee (RNEC)collaborator
- Lawrence Berkeley National Laboratorycollaborator
Study Sites (1)
Dr Evrard Nahimana
Rwinkwavu, Rwanda
Related Publications (1)
Uwamariya J, Mazimpaka C, May L, Nshimyiryo A, Feldman HA, Sayinzoga F, Umutesi S, Gadgil A, Rapp VH, Nahimana E, Hansen A. Safety and effectiveness of a non-electric infant warmer for hypothermia in Rwanda: A cluster-randomized stepped-wedge trial. EClinicalMedicine. 2021 Apr 16;34:100842. doi: 10.1016/j.eclinm.2021.100842. eCollection 2021 Apr.
PMID: 33997734DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Hansen, MD, MPH
Boston Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Director of Neonatal Intensive Care Unit
Study Record Dates
First Submitted
March 21, 2019
First Posted
March 26, 2019
Study Start
November 11, 2019
Primary Completion
July 19, 2020
Study Completion
January 1, 2022
Last Updated
February 11, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share